319 results on '"Cuomo O"'
Search Results
52. Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype
53. Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system
54. D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy
55. Recenti risultati delle ricerche alla Grotta del Pino (Sassano, Salerno)
56. Graft survival is worse in HCV positive females transplanted with male donor grafts
57. Graft survival is worse in HCV positive females transplanted with male donor grafts L
58. Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants
59. Behind D-MELD: The Role of Primary Indication (HCV or HBV) as Significant Covariate in the Outcome Prediction after Liver Transplants
60. Use of HBCAB positive liver organs. Medium term results: according to the Donor –Recipient risk factors
61. Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD in Particluar Reference to a HCV Recipients
62. Long Term Follow-Up (15-20 Years) after Liver Transplantation in Italy: An Observational Multicenter Study
63. WWW.D-MELD.COM THE PROGNOSTIC CALCULATOR TO BALANCE DONOR AND RECIPIENT LIVER TRANSPLANT FACTORS USING D-MELD AND COVARIATES
64. Optimization of donor recipient match and identification of the futile match cutoff a national italian study on liver transplantation
65. Targeting epigenetic regulation of NF-KappaB and histones in the therapy of post-ischemic brain injury
66. Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism
67. Il D-MELD espressione del match donatore-ricevente. Analisi retrospettiva multicentrica italiana relativa al periodo 2002-2009
68. Il graft HBcAb+ nella esperienza trapiantologica italiana (2002-2009). Analisi retrospettiva in rela-zione all’effetto centro ed all’epoca di effettuazione del trapianto
69. Modulation of protein kinase A regulatory subunits distribution after transient brain ischemia
70. La gestione clinica del paziente in lista di attesa
71. Results of a multicenter, randomized, open-label, controlled clinical trial comparing basiliximab versus steroids in hepatitis C positive liver transplant recipients
72. Results of a multicenter, randomized, open-label, controlled clinical trial comparing basiliximab versus steroids in Hepatitis C positive liver transplant patients
73. Results of a multicenter, randomized, open-label trial comparing basiliximab vs. steroids in HCV liver transplant patients
74. Splenectomy and liver transplantation
75. Modulation of liver graft hemodynamics by partial ablation of the splenic circuit: a way to increase hepatic artery flow?
76. Living orthotopic liver transplant using right lobe: our experience in the first 19 donors
77. T-lymphocyte kinetics in acute rejection after orthotopic liver transplantation
78. Telbivudine Prophylaxis for Hepatitis B Virus Recurrence After Liver Transplantation Improves Renal Function
79. Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype
80. Il Riparo del Molare (Salerno): applicazione di un G.I.S. alla paleosuperficie del tg. 56
81. Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients
82. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching
83. Surgery and percutaneous ethanol injection (PEI) as treatment of small hepatocellular carcinoma (HCC): A retrospective case-control study
84. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial
85. Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system.
86. Everolimus Plus Advagraf in Liver Transplanted Patients for HCC: Single Center Experience, One Year Follow-Up
87. Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study
88. Impact of Once-Daily Prolonged-Release Tacrolimus on HCV-Specific Immune Response of Patients Underwent OLTx Compared to Twice a Day Tacrolimus Treatment
89. Side to Side Cavocavostomy in Piggy Back Adult Liver Transplantation
90. Universal Oral Itraconazole Prophylaxis in Liver Transplantation: Boostering Immunosuppressive Drugs While Protecting from Fungal Infection
91. Multiple organ harvesting: evolution of surgical technique--personal experience
92. Role of Liposomal Amphotericin B Prophylaxis After Liver Transplantation Compared With Fluconazole for High-Risk Patients. Impact on Infections and Mortality Within one Year
93. Side-to-Side Cavocavostomy in Adult Piggyback Liver Transplantation
94. Telbivudin as Prophylaxis for Hepatitis B Virus Recurrence After Liver Transplantation: A Case Series in Single-Center Experience
95. 206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS
96. OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants
97. F-46 Graft survival is worse in HCV positive females transplanted with male donor grafts
98. CARCINOMA EPATOCELLULARE IN STADIO T3-T4:UNA CONTROINDICAZIONE AL TRAPIANTO DI FEGATO? ESPERIENZA PERSONALE
99. IL TRAPIANTO DI RENE E DI FEGATO NELL'ANZIANO.ESPERIENZE PERSONALI
100. Multiorgan Retrieval and Horseshoe Kidney: Case Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.